Both Tofacitinib and Azulfidine offer similar effectiveness in symptom control, with the main difference being how quickly they act. Either drug is a viable option depending on the patient’s needs.

Both Tofacitinib and Azulfidine have similar safety profiles, with mild and transient side effects. Neither presents significant long-term safety concerns.

Both Tofacitinib and Azulfidine have a low risk of addiction when used correctly under medical supervision, with minimal potential for misuse.

Both Tofacitinib and Azulfidine are easy to use, with straightforward dosing regimens that ensure good adherence.

Both Tofacitinib and Azulfidine have some contraindications based on individual health conditions, but neither has significantly more restrictions than the other.

Both drugs offer advantages depending on treatment goals. Tofacitinib is great for fast relief, while Azulfidine is better for long-term management. The choice depends on the patient’s specific needs.